Improving Functional Capacity and Quality of Life in Parkinson’s Disease Patients through REAC Neuromodulation Treatments for Mood and Behavioral Disorders

• Published in: Journal of personalized medicine Vol. 13; no. 6; p. 937
• Main Authors: Rinaldi, Chiara, Landre, Cleuton Braga, Volpe, Maria Izabel, Gonçalves, Rebeca Góes, Nunes, Lucas dos Santos, Darienso, Danyela, Cruz, Ana Vitoria, Oliveira, João Douglas, Rinaldi, Salvatore, Fontani, Vania, Barcessat, Ana Rita
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.06.2023; MDPI
• Subjects: Adjustment; Anxiety; Basal ganglia; Care and treatment; Central nervous system diseases; Cognitive ability; Depression, Mental; Development and progression; Dopamine; Epigenetics; Health aspects; Health surveys; Mental depression; Mental disorders; Mental health; Mood; Movement disorders; Neurodegenerative diseases; Neuromodulation; Parkinson's disease; Patients; Posture; Precision medicine; Quality of life; neuromodulation; radio electric asymmetric conveyer technology; non-motor symptoms; motor symptoms; Parkinson; mood and behavioral disorders

Parkinson’s disease is a neurological disorder that affects both motor and non-motor functions, including depression, anxiety, and cognitive decline. Currently, it remains a challenge to distinguish the correlation between these aspects and their impact on one another. To try to clarify these recipr...